Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GLPG

Galapagos (GLPG)

Galapagos
Date:
Sort by:
 Showing the most relevant articles for your search:EU:GLPG
DateTimeSourceHeadlineSymbolCompany
05/16/20244:01PMGlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
05/16/20244:01PMGlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
05/15/20244:01PMGlobeNewswire Inc.Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
05/15/20244:01PMGlobeNewswire Inc.Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
05/02/20244:01PMGlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
05/02/20244:01PMGlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
04/30/20244:01PMGlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
04/30/20244:01PMGlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
04/04/20244:01PMGlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
04/04/20244:01PMGlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
03/28/20244:01PMGlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
03/28/20244:01PMGlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
03/26/20244:01PMGlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
03/26/20244:01PMGlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
02/22/20244:01PMGlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024EU:GLPGGalapagos
02/22/20244:01PMGlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024EU:GLPGGalapagos
02/15/20244:01PMGlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024EU:GLPGGalapagos
02/15/20244:01PMGlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024EU:GLPGGalapagos
01/31/20244:01PMGlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
01/31/20244:01PMGlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
01/04/20244:44PMDow Jones NewsGalapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer DrugEU:GLPGGalapagos
01/04/20244:01PMGlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
01/04/20244:01PMGlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
01/03/20244:01PMGlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyEU:GLPGGalapagos
01/03/20244:01PMGlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyEU:GLPGGalapagos
01/02/20241:00AMGlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
01/02/20241:00AMGlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
12/19/20234:01PMGlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301EU:GLPGGalapagos
12/19/20234:01PMGlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301EU:GLPGGalapagos
12/09/202312:00PMGlobeNewswire Inc.Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101EU:GLPGGalapagos
 Showing the most relevant articles for your search:EU:GLPG